Ibandronate

Category: pharmacological

Aliases: Boniva

Pharmacological Mechanism

Aminobisphosphonate — once-monthly oral or once-quarterly IV dosing for postmenopausal osteoporosis. Lower vertebral-fracture-only evidence vs alendronate / risedronate (no demonstrated hip-fracture reduction).

Half-Life (t½)

PO: 240h, IV: 240h

Dosing Guidelines

• PO: Typical 150mg (Range: 150 - 150 mg)

Target Organ Systems

• musculoskeletal